Kucuk A, Uğur Uslu A, Icli A, Cure E, Arslan S, Turkmen K, Toker A, Kayrak M
Division of Rheumatology, Department of Internal Medicine, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.
Eskişehir Military Hospital, Eskisehir, Rize, Turkey.
Z Rheumatol. 2017 Feb;76(1):58-63. doi: 10.1007/s00393-016-0092-4.
In ankylosing spondylitis (AS) patients, cardiac and vascular involvement may manifest as atherosclerosis and coronary artery disease. Systemic inflammation, oxidative stress, increased low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol constitute a significant risk for atherosclerosis. This study investigated the relationship between carotid intima-media thickness (CIMT), LDL/HDL ratio, total oxidant status (TOS; an indicator of oxidative stress) and ischemic modified albumin (IMA; an ischemic marker in AS patients).
Sixty AS patients were diagnosed using the Modified New York Criteria; 54 age- and gender-matched participants were included as controls. CIMT, LDL/HDL ratio, TOS and IMA were measured using the most appropriate methods.
IMA was higher in AS patients compared to controls (p < 0.0001). TOS was also increased in AS patients (p = 0.005); as was CIMT (p < 0.0001). The LDL/HDL ratio was also greater in AS patients compared to controls (p = 0.047). A positive correlation was found between CIMT and LDL/HDL ratio among AS patients.
Elevated CIMT, IMA and TOS levels suggest an increased risk of atherosclerotic heart disease in AS patients. The LDL/HDL ratio was higher in AS patients compared to controls, and there was a correlation between LDL/HDL ratio and CIMT, albeit statistically weak. Therefore, the LDL/HDL ratio is not a reliable marker to predict atherosclerotic heart disease in AS patients.
在强直性脊柱炎(AS)患者中,心脏和血管受累可能表现为动脉粥样硬化和冠状动脉疾病。全身炎症、氧化应激、低密度脂蛋白(LDL)胆固醇升高和高密度脂蛋白(HDL)胆固醇降低构成动脉粥样硬化的重大风险。本研究调查了颈动脉内膜中层厚度(CIMT)、LDL/HDL比值、总氧化状态(TOS;氧化应激指标)与缺血修饰白蛋白(IMA;AS患者的缺血标志物)之间的关系。
60例AS患者采用改良纽约标准进行诊断;纳入54名年龄和性别匹配的参与者作为对照。使用最合适的方法测量CIMT、LDL/HDL比值、TOS和IMA。
与对照组相比,AS患者的IMA更高(p<0.0001)。AS患者的TOS也升高(p = 0.005);CIMT也是如此(p<0.0001)。与对照组相比,AS患者的LDL/HDL比值也更高(p = 0.047)。在AS患者中,CIMT与LDL/HDL比值之间存在正相关。
CIMT、IMA和TOS水平升高表明AS患者发生动脉粥样硬化性心脏病的风险增加。与对照组相比,AS患者的LDL/HDL比值更高,且LDL/HDL比值与CIMT之间存在相关性,尽管在统计学上较弱。因此,LDL/HDL比值不是预测AS患者动脉粥样硬化性心脏病的可靠标志物。